How Does South Korea Handle The Registration Of Biosimilars?

South Korea regulates biosimilar registration through the Ministry of Food and Drug Safety (MFDS). Companies must submit data proving biosimilarity to the reference product in terms of safety, efficacy, and quality. This includes preclinical and clinical studies, along with manufacturing process details, ensuring the biosimilar meets rigorous regulatory standards before approval.

Leave a Reply

You must be logged in to post a comment.